SCHEMBL38665202

SCHEMBL38665202

CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCOC(=O)NCC(NCCCN(CC)CC)C(=O)OCCCCCCCCOC(=O)C(CCCCCC)CCCCCCCC

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
ATM Q13315 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TLR2 O60603 1/20 0.35
SIRT2 Q8IXJ6 2/20 0.35
PLA2G2A P14555 2/20 0.35
SIRT1 Q96EB6 1/20 0.34
SIRT3 Q9NTG7 1/20 0.34
ACHE P22303 12/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38664642 1.00 CYP3A4 (0.37) CYP3A4TSHRATMTDP1NPC1
SCHEMBL38661775 0.96 CYP3A4 (0.40) CYP3A4TSHRATMTDP1NPC1
SCHEMBL38664451 0.92 DNM1 (0.40) CYP3A4TSHRATMTDP1TLR2
SCHEMBL38663550 0.92 DNM1 (0.40) CYP3A4TSHRATMTDP1TLR2
SCHEMBL38662650 0.92 TLR2 (0.41) CYP3A4TSHRATMTDP1SMN1; SMN2
SCHEMBL38663205 0.90 NPC1 (0.42) NPC1RAB9ASMN1; SMN2TLR2SIRT2
SCHEMBL38662500 0.90 DNM1 (0.41) CYP3A4TSHRATMTDP1NPC1
SCHEMBL38662072 0.90 DNM1 (0.41) CYP3A4TSHRATMTDP1NPC1
SCHEMBL38662061 0.89 CYP3A4 (0.40) CYP3A4TSHRATMTDP1TLR2
SCHEMBL38663264 0.89 TLR2 (0.38) NPC1RAB9ASMN1; SMN2TLR2SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026098671-A1 CATIONIC LIPIDS AND PREPARATION METHOD THEREOF RIBOX THERAPEUTICS HK LIMITED (CN) 2026-05-15 WO disclosed